Home > Boards > US OTC > Delisted > Aralez Pharmaceuticals Inc. (fka ARLZQ)

ARLZQ...004...Nice move to .0115 followed by a dip

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
georgie18 Member Profile
Member Level 
Followed By 1,488
Posts 74,552
Boards Moderated 8
Alias Born 12/17/11
160x600 placeholder
georgie18 Member Level  Monday, 01/21/19 06:34:43 AM
Re: None
Post # of 470 
ARLZQ...004...Nice move to .0115 followed by a dip to the .002 range which left an open gap in the .006 range that should fill...

Chart...http://schrts.co/eQegvnDT

https://www.otcmarkets.com/filing/html?id=13162447&guid=dBktUn0Vr9ul-th

Effective as of January 18, 2019, Sanjay Subramanian, 43, the Company’s current Treasurer, will assume the role of Chief Financial Officer. Prior to joining the company, Mr. Subramanian was the Director of Treasury at Bausch Health Companies. Mr. Subramanian started his finance career at General Motors Co. where he held various positions before leaving as the Treasurer of GM Korea.

Effective as of January 31, 2019, Christopher Freeland, 40, the Company’s current General Counsel, will also assume the role of Chief Operating Officer. Prior to being appointed as the Company’s General Counsel, Mr. Freeland was the Company’s Associate General Counsel. Prior to joining the Company, Mr. Freeland was an Associate General Counsel at American International Group. Mr. Freeland started his legal career as a corporate associate at Willkie Farr & Gallagher LLP.





I smell sex and candy here
Who's that lounging in my chair
Who's that casting devious stares
In my direction
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist